Cargando…
Treatment with XAV-939 prevents in vitro calcification of human valvular interstitial cells
The development of a substance or inhibitor-based treatment strategy for the prevention of aortic valve stenosis is a challenge and a main focus of medical research in this area. One strategy may be to use the tankyrase inhibitor XAV-939, which leads to Axin stabilisation and subsequent destruction...
Autores principales: | Dittfeld, Claudia, Reimann, Gabriel, Mieting, Alice, Büttner, Petra, Jannasch, Anett, Plötze, Katrin, Steiner, Gerald, Tugtekin, Sems Malte, Matschke, Klaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286025/ https://www.ncbi.nlm.nih.gov/pubmed/30532256 http://dx.doi.org/10.1371/journal.pone.0208774 |
Ejemplares similares
-
Infrared Spectroscopic Verification of a α-Helical Collagen Structure in Glutaraldehyde-Free Crosslinked Bovine Pericardium for Cardiac Implants
por: Welzel, Cindy, et al.
Publicado: (2022) -
Optical coherence tomography and multiphoton microscopy offer new options for the quantification of fibrotic aortic valve disease in ApoE(−/−) mice
por: Jannasch, Anett, et al.
Publicado: (2021) -
Bioactivity Studies of Hesperidin and XAV939
por: Fazary, Ahmed E., et al.
Publicado: (2021) -
Challenges of aortic valve tissue culture – maintenance of viability and extracellular matrix in the pulsatile dynamic microphysiological system
por: Dittfeld, Claudia, et al.
Publicado: (2023) -
XAV939-Mediated ARTD Activity Inhibition in Human MB Cell Lines
por: Renna, Cristiano, et al.
Publicado: (2015)